Search clinical trials for: Soluble Fms-like- tyrosine kinase 1

Total 54969 results

Novartis Pharmaceuticals

Completed

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
University of Göttingen
King's College London; Università degli Studi di Brescia

Recruiting

Epigenetics in Lupus Nephritis (Epi_LN)

Systemic Lupus Erythematosus | Lupus Nephritis

Germany
GlaxoSmithKline

Completed

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Mexico, South Africa
National University of Malaysia

Completed

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus (GLP-1)

Type 2 Diabetes Mellitus | PreDiabetes

Malaysia
Bayer

Active, not recruiting

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice (FINEGUST)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Japan, Spain, Netherlands, United Kingdom, Denmark, United States
ConjuChem

Terminated

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

United States, Canada
Benha University

Unknown

Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?

Ovary Cyst

Egypt
GlaxoSmithKline

Completed

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

Diabetes Mellitus, Type 2

United States
University of North Carolina, Chapel Hill

Recruiting

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Gastroparesis | Delayed Gastric Emptying

United States
Xeris Pharmaceuticals

Completed

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Hypoglycemia | Diabetes Mellitus, Type 1

United States, Canada
Ankara Yildirim Beyazıt University

Recruiting

Investigation of the Effects of Robot Assisted Gait Training With Virtual Reality on Cognitive Functions in Stroke Patients

Stroke | Exoskeleton Device | Locomotion

Turkey
Teesside University

Completed

Strength and Fundamental Movement Skill (FMS) Training in Children

Fundamental Movement Skill Competence

United Kingdom
The Catholic University of Korea
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Korea, Republic of
Bispebjerg Hospital

Completed

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes. (EGOFIP)

Type 2 Diabetes | Microvascular Dysfunction

Denmark
AstraZeneca

Completed

Clinical Outcomes of Exenatide Versus Basal Insulin

Type 2 Diabetes

United Kingdom
National Institute on Drug Abuse (NIDA)

Recruiting

Semaglutide Therapy for Alcohol Reduction (STAR)

Addiction | Alcohol Use Disorder

United States
Second Xiangya Hospital of Central South University
Guangdong Provincial People's Hospital; The First Affiliated Hospital of Henan... and other collaborators

Recruiting

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Diabetes Mellitus, Type 2 | Overweight or Obesity

China
University of Alabama at Birmingham

Completed

TLR4 Polymorphisms and Risk of Skin Cancer

Skin Cancer

United States
Christine Hunter
Merz North America, Inc.

Completed

Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy

Flu-like Symptoms

United States
Hoffmann-La Roche

Completed

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Diabetes Mellitus Type 2

Australia, United States, France, Germany, Mexico, Puerto Rico, Peru
Xenikos

Completed

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Graft vs Host Disease

Netherlands, Germany
University Hospital, Gentofte, Copenhagen

Completed

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

Obesity | Incretin Action

Denmark
Eli Lilly and Company
Locemia Solutions ULC

Completed

Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia

Diabetes Mellitus | Hypoglycemia | Drug-Specific Antibodies

United States, Canada
Medco Health Solutions, Inc.
Celera Genomics

Completed

Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS)

Cardiovascular Diseases | Dyslipidemia

United States
Merck Sharp & Dohme LLC

Recruiting

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

Esophageal Squamous Cell Carcinoma (ESCC)

Japan, Korea, Republic of, Taiwan, Italy, Thailand, France, Turkey, Switzerland, Brazil, Singapore, Germany, Chile, Norway
University Hospital, Basel, Switzerland

Completed

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Appetite and General Nutritional Disorders | Hormone Replacement

Switzerland
Xeris Pharmaceuticals
Integrated Medical Development

Terminated

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United States
Tianjin First Central Hospital

Not yet recruiting

FSTL1 and PPCs on Pediatric Within LDLT:a Prospective Cohort Analysis

Liver Transplant; Complications | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Pulmonary Complication
Hoffmann-La Roche

Completed

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Diabetes Mellitus Type 2

Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
Vanderbilt University Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) (GATA-3)

Asthma

United States
Cambridge University Hospitals NHS Foundation Trust

Completed

Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers (COCOA)

Cardiovascular Diseases

United Kingdom
University Hospital, Basel, Switzerland

Completed

Oral Glucose Stimulation in Normal-weight and Obese Volunteers

Endocrine System Diseases

Switzerland
University College, London

Completed

Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response (BARIOPTIMISE)

Obesity

United Kingdom
Ankara Yildirim Beyazıt University

Completed

Functional Movement Analysis (FMS) of Diaphragmatic Breathing-Immediate Effect on Shoulder Mobility

Shoulder Pain | Diaphragm Issues

Turkey
University of Aarhus

Completed

Metabolic and Inflammatory Responses to Hemodialysis and the Effect of a Meal

Kidney Failure, Chronic

Denmark
Oncternal Therapeutics, Inc
University of California, San Diego; Pharmacyclics LLC.; California Institute...

Active, not recruiting

A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies

Mantle Cell Lymphoma | Marginal Zone Lymphoma | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
The University of Hong Kong

Completed

Working Memory and Social-emotional Training for Preschoolers at Risk of ADHD

ADHD | Social Skills | Working Memory | Time Perception Altered

Hong Kong
Association Francaise pour la Recherche Thermale
University Hospital, Grenoble; Floralis

Completed

Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis

Plaque Psoriasis

France
AstraZeneca
Parexel

Terminated

A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Type 2 Diabetes

United States
University Hospital, Geneva

Not yet recruiting

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Diabetes Mellitus, Type 2 | Anesthesia | Pulmonary Aspiration of Gastric Contents
TCI Co., Ltd.

Recruiting

Evaluation of Human Efficacy of SOD Like Super Drink

Dermatology

Taiwan
National Cancer Institute (NCI)

Terminated

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Rhabdomyosarcoma | Rhabdomyosarcoma, Alveolar | Rhabdomyosarcoma, Embryonal

United States
Assiut University

Not yet recruiting

The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis

Multiple Sclerosis
AdventHealth Translational Research Institute

Active, not recruiting

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects (GIO B)

Obesity

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
University Hospital, Gentofte, Copenhagen
Merck Sharp & Dohme LLC

Completed

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Denmark
Novo Nordisk A/S

Completed

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III

Healthy Participants

Canada
Novo Nordisk A/S

Active, not recruiting

DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy (DOORS)

Diabetes Mellitus, Type 2

Italy
University of Chile
Sociedad Chilena de Nutrición

Completed

To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM

Diabetes Mellitus, Type 2
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1) (OASIS 1)

Obesity | Overweight

Germany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan

Search clinical trials for: Soluble Fms-like- tyrosine kinase 1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations